On Thursday, 19th June 2025, Dr Preema London Clinic marked the launch of the innovative BTL EXOMIND™ treatment with a dedicated press day at its Park Lane clinic.
The event introduced health, wellness, and aesthetics media to ExoTMS™, the new and cutting-edge, non-invasive neurostimulation technology powering BTL EXOMIND™, which is designed to support cognitive clarity, emotional balance, and aid stress management.
During the launch, guests experienced one-to-one consultations and live demonstrations with Dr Preema Vig, advanced aesthetic doctor, and her team. The personalised sessions offered first-hand insight into how EXOMIND™ can become an integral part of both mental health and aesthetic routines.
Science-Backed Mental Wellness Without Medication
EXOMIND™ is based on decades of neuroscience research and delivers targeted electromagnetic pulses to stimulate the dorsolateral prefrontal cortex—a key brain region involved in mood regulation, decision-making, and cognitive function. This stimulation strengthens neuroplasticity, improves communication between neurons, and triggers the release of natural neurotransmitters like serotonin and dopamine to help stabilise mood.
FDA-cleared in the USA for depression and CE-marked in Europe for depression, anxiety, OCD, and binge eating, EXOMIND™ is evidence-based, non-invasive, and requires no downtime. In clinical studies, 98% of patients reported improved clarity of thought, while 92% experienced better emotional balance.
“Mental wellbeing underpins everything—from how we feel in our skin to how we perform in life. EXOMIND™ bridges the emotional, cognitive, and aesthetic realms, offering a deeply integrative approach to wellness. It’s the missing piece in the beauty-wellness puzzle.”
Dr Preema Vig
